MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Kendle’s Q4 drags 2010 into the red
Kendle International Inc. (NSDQ:KNDL) reported losses of $9.2 million, or 62 cents per diluted share, on sales of $107.9 million during the three months ended Dec. 31, 2010. That compares with profits of about $2.3 million, or 16 cents per diluted share, on sales of $130.9 million during the same period in 2009.
Full-year losses were $4.6 million, or 31 cents per diluted share, on sales of $448.3 million. That compares with profits of $15.2 million, or $1.02 cents per diluted share, on sales of $551.9 million in 2009.
Read more
Natus’ annual revenues jump 31 percent
Natus Medical Inc. (NSDQ:BABY) reported profits of $5.2 million or 18 cents per diluted share, on sales of $63.2 million during the three months ended Dec. 31. That compares with profits of $4.1 million, or 14 cents per diluted share, on sales of $51.4 million during the same period last year.
Full-year profits were $12.1 million, or 41cents per diluted share, on sales of $218.7 million. That compares with profits of $11.3 million, or 40 cents per diluted share, on sales of $166.4 million in 2009.
Read more
Tornier losses ease as sales get significant bump
Tornier N.V. (NYSE:TRNX) reported losses of $8.1 million, or 27 cents per diluted share, on sales of $61.3 million during the three months ended Jan. 2. That compares with a losses of $30.8 million, or $1.25 per diluted share, on sales of $57.3 million during the same period in 2009.
Full-year losses were $38.8 million, or $1.42 per diluted share, on sales of $227.4 million. That compares with losses of $54.6 million, or $2.28 cents per diluted share, on sales of $201.5 million in 2009.
Read more
ERT results mixed despite big drop in sales
eResearchTechnology Inc. (NSDQ:ERES) reported profits of $3.3 million, or 7 cents per diluted share, on sales of $23.1 million during the three months ended Dec. 31, 2010. That compares with profits of $4.1 million, or 8 cents per diluted share, on sales of $44.9 million during the same period in 2009.
Full-year profits were $10.7 million, or 22 cents per diluted share, on sales of $93.8 million. That compares with profits of $9.9 million, or 20 cents per diluted share, on sales of $141.0 million in 2009.
Read more
MAKO Surgical losses widen despite 30 percent sales jump
MAKO Surgical Corp. (NSDQ:MAKO) reported losses of $9.8 million or 26 cents per diluted share, on sales of $14.8 million during the three months ended Dec. 31. That compares with losses of $9.3 million, or 28 cents per diluted share, on sales of $8.9 million during the same period last year.
Full-year losses were $38.7 million, or $1.13 per diluted share, on sales of $44.3 million. That compares with losses of $34.0 million, or $1.22 per diluted share, on sales of $34.2 million in 2009.
Read more
Essilor profits, sales see healthy increases
Essilor International (EPA:EI) reported sales of $1.37 billion during the three months ended Dec. 31. That compares with sales of $1.11 billion during the same period last year.
Full-year profits were $640.4 million, or $3.02 per diluted share, on sales of $5.39 billion. That compares with profits of $541.6 million, or $2.61 per diluted share, on sales of $4.53 billion in 2009. Data reported in today’s EUR to USD exchange rates.
Read more
Cyberonics’ lower Q3 sales ding profits
Cyberonics Inc. (NSDQ:CYBX) reported profits of $7.2 million, or 25 cents per diluted share, on sales of $47.1 million during the 13 weeks ended Jan. 28. That compares with a profits of $8.8 million, or 29 cents per diluted share, on sales of $40.8 million during the same period in 2009.
Read more